Perfusion imaging with arterial spin labeling (ASL)-MRI predicts malignant progression in low‑grade (WHO grade II) gliomas.
Christina Maria FliesTom Jan SnijdersTom Van SeetersMarion SmitsFilip Yves Francine De VosJeroen HendrikseJan Willem DankbaarPublished in: Neuroradiology (2021)
Perfusion imaging with ASL-MRI can predict malignant progression within 12 months in patients with grade II glioma.